Affymetrix, Inc. (NASDAQ:AFFX)
CAPS Rating:
Engaged in the development, manufacture, sale and service of consumables and systems for genetic analysis in the life sciences and clinical healthcare markets and create tools that advances the understanding of the molecular basis of life.
RSS Headlines
Fool UK
Recs
Knocked down quite badly today, but genetic testing is ramping up. As it becomes more common for companies to turn to this, AFFX will continue to grow.